"Atherosclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.
| Descriptor ID |
D050197
|
| MeSH Number(s) |
C14.907.137.126.307
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Atherosclerosis".
Below are MeSH descriptors whose meaning is more specific than "Atherosclerosis".
This graph shows the total number of publications written about "Atherosclerosis" by people in this website by year, and whether "Atherosclerosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 4 | 1 | 5 |
| 2006 | 2 | 2 | 4 |
| 2007 | 8 | 7 | 15 |
| 2008 | 11 | 6 | 17 |
| 2009 | 8 | 4 | 12 |
| 2010 | 10 | 4 | 14 |
| 2011 | 11 | 3 | 14 |
| 2012 | 9 | 1 | 10 |
| 2013 | 15 | 2 | 17 |
| 2014 | 11 | 3 | 14 |
| 2015 | 9 | 1 | 10 |
| 2016 | 8 | 3 | 11 |
| 2017 | 11 | 1 | 12 |
| 2018 | 13 | 3 | 16 |
| 2019 | 7 | 1 | 8 |
| 2020 | 6 | 3 | 9 |
| 2021 | 10 | 4 | 14 |
| 2022 | 11 | 0 | 11 |
| 2023 | 13 | 0 | 13 |
| 2024 | 9 | 2 | 11 |
| 2025 | 7 | 1 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Atherosclerosis" by people in Profiles.
-
Poor olfaction and risk of heart failure in the Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci. 2025 Oct 05; 80(11).
-
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis. J Am Coll Cardiol. 2025 Oct 07; 86(14):1046-1056.
-
A prometabolite strategy inhibits cardiometabolic disease in an ApoE-/- murine model of atherosclerosis. JCI Insight. 2025 Aug 08; 10(15).
-
Caloric restriction promotes resolution of atherosclerosis in obese mice, while weight regain accelerates its progression. J Clin Invest. 2025 Sep 16; 135(18).
-
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk. N Engl J Med. 2025 Jul 03; 393(1):51-61.
-
Geographic and Sociodemographic Factors and Receipt of Metabolic Disease Specialty Care. JAMA Netw Open. 2025 05 01; 8(5):e2511559.
-
Longitudinal Association of Olfactory Function with Frailty in Older Adults: The Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci. 2025 Mar 07; 80(4).
-
Poor Olfaction and Risk of Stroke in Older Adults: The Atherosclerosis Risk in Communities Study. Stroke. 2025 Feb; 56(2):465-474.
-
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial. JAMA Cardiol. 2024 Sep 01; 9(9):808-816.
-
Impact of aspirin dose according to race in secondary prevention of atherosclerotic cardiovascular disease: a secondary analysis of the ADAPTABLE randomised controlled trial. BMJ Open. 2024 08 07; 14(8):e078197.